AskVantage

VerImmune

VerImmune is a startup headquartered in Bethesda, United States, founded in 2019. It has raised at least $4.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory. Last updated .

2019Founded
StartupStage
Bethesda, United StatesHeadquarters
BiotechnologyIndustry
$4.5m+Raised (SEC filings)
SeedFunding stage
Biotechnology
See it on the interactive mapBook a Briefing

Funding

VerImmune has raised at least $4.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

VerImmune sits inside the Washington DC and Maryland R&D ecosystem in the Global R&D Labs Directory.

Other startups in Bethesda

Related

Questions and answers

What does VerImmune do?

VerImmune is classed in biotechnology in its filings with the US Securities and Exchange Commission.

How much has VerImmune raised?

At least $4.5m, according to its Form D filings with the US Securities and Exchange Commission.

Where is VerImmune based?

VerImmune is headquartered in Bethesda, United States.

When was VerImmune founded?

VerImmune was founded in 2019.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.